Cargando…
Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS
With a growing aged population, there is an imminent need to develop new therapeutic strategies to ameliorate disorders of hematopoietic aging, including clonal hematopoiesis and myelodysplastic syndrome (MDS). Cell-intrinsic dysregulation of innate immune- and inflammatory-related pathways as well...
Autores principales: | Trowbridge, Jennifer J., Starczynowski, Daniel T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210621/ https://www.ncbi.nlm.nih.gov/pubmed/34129017 http://dx.doi.org/10.1084/jem.20201544 |
Ejemplares similares
-
Progressive disruption of hematopoietic architecture from clonal hematopoiesis to MDS
por: Buck, Michèle C., et al.
Publicado: (2023) -
What Clonal Hematopoiesis Can Teach Us About MDS
por: Chan, Irenaeus C. C., et al.
Publicado: (2022) -
Clonal Hematopoiesis, Cardiovascular Diseases and Hematopoietic Stem Cells
por: Kandarakov, Oleg, et al.
Publicado: (2020) -
IRAK1: oncotarget in MDS and AML
por: Beverly, Levi J., et al.
Publicado: (2014) -
The role of innate immunity in MDS pathogenesis
por: Sallman, David A., et al.
Publicado: (2019)